mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
0.045 |
0.3 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.047 |
0.3 |
mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.3 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |